ZBH 📈 Zimmer Biomet Holdings - Overview

Zimmer Biomet Holdings Inc, a global medical technology company, operates through a diverse range of subsidiaries to design, manufacture, and market an extensive portfolio of orthopedic reconstructive products. These products encompass a broad spectrum, including knee and hip replacement systems, as well as a variety of sports medicine, biologics, foot and ankle, extremities, and trauma products. The company's product line also extends to craniomaxillofacial and thoracic solutions, which are utilized in face and skull reconstruction procedures, and in stabilizing chest bones following open heart surgery, trauma, or to correct chest deformities.

The company's offerings further include advanced robotic and surgical systems, alongside bone cement products, all of which play critical roles in treating patients with bone, joint, or soft tissue disorders or injuries. By providing these innovative solutions, Zimmer Biomet supports a wide range of medical professionals, including orthopedic surgeons, neurosurgeons, and other specialists, in addition to hospitals, distributors, and healthcare organizations. This comprehensive approach enables the company to address a broad array of patient needs, contributing to improved outcomes and quality of life for individuals worldwide.

With a history dating back to 1927, Zimmer Biomet has evolved significantly over the years, including a name change from Zimmer Holdings, Inc. to Zimmer Biomet Holdings, Inc. in June 2015, following its merger with Biomet, Inc. Headquartered in Warsaw, Indiana, the company is listed on the New York Stock Exchange under the ticker symbol ZBH and is classified under the common stock category with the ISIN US98956P1021. As a key player in the health care equipment sector, Zimmer Biomet's commitment to innovation, customer satisfaction, and patient care has positioned it as a leading global medical technology company, with its official website available at https://www.zimmerbiomet.com.